Cognition Therapeutics sued by former CEO for $4M


Complaint alleges Pittsburgh-founded biopharm company cost exec millions due to how it handled his stock options.

Previous The Punch List: Columbus Partnership helps give downtown building new life, VanTrust's newest project and more in our weekly real estate roundup
Next Bank of Texas promotes Dallas-based executive to CEO role